ADMA ADMA Biologics, Inc. · $8.71 Lagging — relative weakness落后 — 相对弱势 Terminal终端 ↗

All coverage所有股票 · Health Care

ADMA Biologics, Inc. · Health Care

ADMA

$8.71
Mixed profile混合特征 Mid cap中盘 $2B
Engine stance引擎立场2026-07-20
Lagging — relative weakness落后 — 相对弱势
The bottoming setup is not yet confirmed (price still below the 10-day average) and oscillators are already extended/ove筑底形态尚未确认（价格仍位于 10 日均线下方），且摆动指标已过热——此处入场风险较高。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Open in Terminal打开终端 ↗ All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$8.71
57.3% below 52-week high低于52周高点 57.3%
Market Cap市值
$2B
Normal volume正常成交量
P/E Ratio市盈率
14.1x
28.9x sector median
Beta贝塔
0.89
Moves about 0.9x the market波动幅度约为市场的 0.9 倍
RSI (14)RSI（14）
48
Neutral zone中性区域
Next Earnings下次财报
2026-08-05 (17d)
Volatility Rank波动率分位
3th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
10.2% of float

Performance价格表现

Period周期 ADMA S&P 500vs Index对比指数
1 Week近1周 -4.1% -1.5% Lagged the index by 2.6 points落后指数 2.6 个百分点
1 Month近1月 +3.4% +0.6% Beat the index by 2.8 points跑赢指数 2.8 个百分点
3 Months近3月 -20.9% +4.7% Lagged the index by 25.6 points落后指数 25.6 个百分点
6 Months近6月 -49.7% +7.8% Lagged the index by 57.5 points落后指数 57.5 个百分点
Year to date年初至今 -51.3% +9.1% Lagged the index by 60.4 points落后指数 60.4 个百分点
1 Year近1年 -50.5% +19.4% Lagged the index by 69.9 points落后指数 69.9 个百分点
3 Years近3年 +144.0% +69.4% Beat the index by 74.6 points跑赢指数 74.6 个百分点

Technicals技术面

RSI (14)RSI（14） 48 Neutral zone中性区域
vs 50-day相对50日均线 +2.6% vs 50-day avg
vs 200-day相对200日均线 -36.2% vs 200-day avg
Volatility rank波动率分位 3th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$8.48
Don't chase above不追高于
$8.71
Stop止损
$8.21
Extended — wait for a pullback过度拉伸 — 等待回撤

Earnings财务业绩

17
days until next report天后公布财报
2026-08-05

Estimates being cut预期下调

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 ADMA Sector median行业中位 Cheaper than相对便宜
P/E (trailing)市盈率（历史） 14.10x 28.92
87%
P/B市净率 4.34x 3.52
39%
P/S市销率 4.06x 3.02
38%
Earnings yield盈利收益率 7.09% 2.72
91%
FCF yield自由现金流收益率 1.34% 3.94
20%
Shareholder yield股东收益率 1.54% 1.89
42%
EV/EBITDA企业价值/EBITDA 10.31x 18.21
89%
P/FCF市值/自由现金流 74.47x 22.42
8%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$42.2M
2020
$80.9M
2021
$154.1M
2022
$258.2M
2023
$426.5M
2024
$510.2M
2025
5yr CAGR5年复合增速: 64.6%
Earnings Per Share每股收益
$-0.88
2020
$-0.51
2021
$-0.33
2022
$-0.13
2023
$0.81
2024
$0.60
2025
Free Cash Flow自由现金流
-$114.7M
2020
-$125.9M
2021
-$73.4M
2022
$4.0M
2023
$110.4M
2024
$27.8M
2025
Margins利润率
Gross margin毛利率
57.4%
Operating margin营业利润率
37.5%
Net margin净利率
28.8%
FCF margin自由现金流利润率
9.9%
30.8%Return on Equity股本回报率
23.5%Return on Assets资产回报率
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.08
Current ratio流动比率6.71
Capital Allocation资本配置
Buybacks (TTM)回购（TTM）$31.9M
Stock-based comp股权薪酬$20.0M
Share count change (1y)股数变化（1年）+0.5%
Piotroski皮奥特罗斯基 4/8 Altman Z阿尔特曼Z: safe (10.7) Watch关注

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 55% of its sector on blended multiples综合估值倍数低于行业内 55% 的公司
Beta市场敏感度
0.89×
0.21×3×
Moves about 0.9× the market波动幅度约为市场的 0.9 倍
Financial Health财务健康
4/8
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息

Why Is It Moving为何波动

News新闻 2 recent stories — mixed2 篇最新报道，多空参半
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed +13.9%空头仓位变动 +13.9%
Technical技术面 ADMA daily MACD crossed downADMA 日线MACD下穿

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$1.7M net (1 buyers, 2 sellers)-$1.7M 净值（1 买家，2 卖家）
Concentrated ownership集中持仓
Fund基金 Grade评级 Activity动作 % of portfolio组合占比 As of截至
Duquesne Family Office (Druckenmiller) C Adding加仓 0.4% 2026-03-31
Perceptive Advisors A trimtrim 0.1% 2026-03-31
Sachem Head Capital D exitexit 0.0% 2026-03-31

Signal History信号历史

UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP. Buyers rejected the 2026-06-12 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all. Last cycle was left-translated (topped early) — a bearish structural tell买入预备。买方拒绝了 2026-06-12 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
TURN SIGNALED BOTTOMING
Jul 17, 2026
ADMA daily MACD crossed downADMA 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $8.71.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$8.71。
Jul 13, 2026
UNCONFIRMED TURN → UPTREND未确认转向 → 上涨趋势
HOLD持有
Jul 3, 2026
ADMA weekly MACD crossed upADMA 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Jul 1, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 29, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Jun 24, 2026
UPTREND → UNCONFIRMED TURN上涨趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Jun 22, 2026
UNCONFIRMED TURN → UPTREND未确认转向 → 上涨趋势
HOLD持有

Showing last 15 of显示最近15条，共 243 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.60
Value价值
-0.4
Profitability盈利能力
+0.9
Quality质量
-1.3
Investment资本投入
-1.1
Shareholder payout股东回报
-0.6
Low volatility低波动
-1.0
Low market beta低市场敏感度
-0.1
Earnings quality盈利质量
-3.0
Short interest空头兴趣
-1.1

Company Profile公司档案

Watch items — what could change the thesis关注项 — 可能改变论点的因素
  • Receivables stretch
  • Capital intensity rising

Recent News最新动态

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA GlobeNewswire Inc. 2026-07-19
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit GlobeNewswire Inc. 2026-07-17
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。
Open Analyzer打开分析器 Browse All Stocks浏览所有股票